ArticleBlood advances2025

Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulation.

Cho-Han Chiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.